Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix
July 29, 2021 16:05 ET
|
Bioventus, Inc.
Significantly Expands TAM and Adds Considerable Scale and Scope in Spine and Lower ExtremityEnhances Surgical Solutions Vertical by Adding Minimally Invasive Ultrasonic Technologies That Improve...
Bioventus Inc. Reports Preliminary Second Quarter Net Sales; Updates Full-Year 2021 Net Sales Guidance
July 29, 2021 16:00 ET
|
Bioventus, Inc.
DURHAM, N.C., July 29, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported preliminary financial...
Bioventus® Management to Present at Canaccord Genuity Growth Conference and Morgan Stanley Virtual Global Healthcare Conference
July 27, 2021 16:15 ET
|
Bioventus, Inc.
DURHAM, N.C., July 27, 2021 (GLOBE NEWSWIRE) -- Senior management of Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, will present at...
Bioventus Appoints Mary Kay Ladone to Board of Directors
July 14, 2021 16:05 ET
|
Bioventus, Inc.
DURHAM, N.C., July 14, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has announced the appointment of Mary...
Bioventus Launches OSTEOAMP® SELECT Flowable Nationwide
July 13, 2021 08:30 ET
|
Bioventus, Inc.
DURHAM, N.C., July 13, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, is launching OSTEOAMP SELECT Flowable,...
Bioventus Invests in Vaporox
June 24, 2021 16:36 ET
|
Bioventus, Inc.
DURHAM, N.C., June 24, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has completed a minority investment in...
Bioventus to Release Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021
June 16, 2021 16:05 ET
|
Bioventus, Inc.
DURHAM, N.C., June 16, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that second quarter of...
Bioventus Study Shows Novel Placental Tissue Biologic Candidate Inhibited Inflammatory and Catabolic Responses In Vitro
May 25, 2021 09:00 ET
|
Bioventus, Inc.
DURHAM, N.C., May 25, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced human placental tissue,...
Bioventus Senior Management to Present at Upcoming Investor Conferences
May 17, 2021 08:15 ET
|
Bioventus, Inc.
DURHAM, N.C., May 17, 2021 (GLOBE NEWSWIRE) -- Senior management of Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, will present at...
Bioventus Inc. Reports First Quarter Results; Updates Full Year 2021 Financial Guidance
May 12, 2021 16:05 ET
|
Bioventus, Inc.
DURHAM, N.C., May 12, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...